Open App
you are here:
Success
Alert
Please select a Day.
Info
46.70
0.35 (0.76%)

As on 04 Oct, 2022 | 03:59

Trade Trade
Day Range
46.20
47.30
L H
52 Week Range
38.60
78.00
L H
Volume
825,094
*
i

* BSE Market Depth (04 Oct 2022)

BUY SELL
QTY PRICE PRICE QTY
1498 46.60 46.70 7
500 46.25 46.75 157
697 46.20 46.85 50
100 46.15 46.90 141
547 46.10 46.95 100
0 Total Total 0
Bid / Ask
0.00 / 0.00
46.65
0.35 (0.76%)

As on 04 Oct, 2022 | 04:01

Day Range
46.20
47.20
L H
52 Week Range
38.70
77.70
L H
Volume
69,891
*
i

* BSE Market Depth (04 Oct 2022)

BUY SELL
QTY PRICE PRICE QTY
1498 46.60 46.70 7
500 46.25 46.75 157
697 46.20 46.85 50
100 46.15 46.90 141
547 46.10 46.95 100
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
MC Essentials
63% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights
Mid-range performer

Stock with medium financial performance with average price momentum and val

Financials
    Ownerships
      Industry Comparison
        Others
          Open47.00
          Previous Close46.35
          Volume825,094.00
          Value (Lacs)385.32
          i  VWAP 46.67
          Beta1.010.96
          High47.30
          Low46.20
          UC Limit55.60
          LC Limit37.10
          52 Week High78.00
          52 Week Low38.60
          TTM EPS4.49
          TTM PE10.40
          Sector PE29.36
          Book Value Per Share29.88
          P/B1.57
          Face Value1.00
          Mkt Cap (Rs. Cr.)1,911
          Dividend Yield0.54
          20D Avg Volume691,586
          20D Avg Delivery(%)61.65

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Mid-range performer
          Stock with medium financial performance with average price momentum and val

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 40.13% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above industry Median

          Shareholding Pattern
          • Promoters holding remains unchanged at 48.25% in Jun 2022 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          News

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Marksans Pharma

          What's your call on Marksans Pharma today?

          Read 2 investor views

          BUY SELL HOLD

          Broker Research

          19 Aug, 2022

          Arihant capital markets

          Reco Price 50.90 Target Price 80
          06 Jun, 2022

          Arihant capital markets

          Reco Price 45.95 Target Price 80
          16 Feb, 2022

          Arihant capital markets

          Reco Price 52.80 Target Price 86
          01 Jun, 2021

          Arihant capital markets

          Reco Price 73.60 Target Price 86
          11 Jun, 2018

          Centrum Broking

          Reco Price 29.20 Target Price 31
          11 Jun, 2018

          Centrum Broking

          Reco Price 29.20 Target Price 31

          Deals

          18 Nov, 2008

          ANJALI CHAWLA

          Qty 1995747 Price 6.03 % Traded 0.49
          18 Nov, 2008

          KABUL CHAWLA

          Qty 1995747 Price 6.03 % Traded 0.49

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          15 Jun, 2021

          GRAVITON RESEARCH CAPITAL LLP

          Qty 3004279 Price 93.18 % Traded 0.73
          15 Jun, 2021

          CRONY VYAPAR PVT LTD

          Qty 2900172 Price 93.75 % Traded 0.71
          15 Jun, 2021

          GRAVITON RESEARCH CAPITAL LLP

          Qty 3004279 Price 93.09 % Traded 0.73
          15 Jun, 2021

          CRONY VYAPAR PVT LTD

          Qty 2800172 Price 93.69 % Traded 0.68
          14 Jun, 2021

          GRAVITON RESEARCH CAPITAL LLP

          Qty 4772250 Price 92.29 % Traded 1.17
          14 Jun, 2021

          PARTH INFIN BROKERS PVT LTD

          Qty 3011733 Price 94.6 % Traded 0.74
          14 Jun, 2021

          XTX MARKETS LLP

          Qty 2814707 Price 92.19 % Traded 0.69
          14 Jun, 2021

          VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITED

          Qty 2755545 Price 90.87 % Traded 0.67

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          02 Mar, 2020

          Mr. Sebastian Pereira

          Employee
          Qty 5000 Price 85.08 % Traded 0.00 Post Tnx Hold. 0%
          02 Mar, 2020

          Mr. Sebastian Pereira

          Employee
          Qty 2800 Price 95.22 % Traded 0.00 Post Tnx Hold. 0%
          02 Mar, 2020

          Mr. Sebastian Pereira

          Employee
          Qty 100 Price 104.63 % Traded 0.00 Post Tnx Hold. 0%
          02 Mar, 2020

          Mr. Sebastian Pereira

          Employee
          Qty 5100 Price 108.6 % Traded 0.00 Post Tnx Hold. 0%
          22 Sep, 2016

          Harsh Trehon

          Employee
          Qty 69900 Price 49.74 % Traded 0.02 Post Tnx Hold. 0%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          No Data For Substantial Acquisition of Shares & Takeovers.

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Marksans Pharma 46.70 0.76 1,911.49 10.40 1.56 15.53 -36.20 186 1,490 0.03
          Sun Pharma 944.55 0.01 226,629.18 58.27 4.44 6.81 13.53 3,405 38,654 0.02
          Divis Labs 3,780.10 1.43 100,349.78 32.31 8.56 25.24 -27.59 2,960 8,959 0.00
          Cipla 1,144.65 1.23 92,373.44 36.83 4.37 12.07 19.55 2,559 21,763 0.04
          Dr Reddys Labs 4,413.95 -0.13 73,477.62 24.56 3.82 11.35 -12.47 2,112 21,545 0.16

          About the Company

          Marksans Pharma Limited together with its subsidiaries operates as an integrated international pharmaceutical company. The Companys business is distribution of pharmaceutical products. It is actively engaged in research and development (R&D) and offering contract research and manufacturing services (CRAMS) to global pharmaceutical companies. The R&D capability of the Company includes dossier development service, formulation development and specified drug delivery system. The Companys domestic formulation business is the specialty division, which mainly focuses on oncology and critical care therapy. The brands of this division are MARKPARIN and EPIGROF. EPIGROF is also being supplied to hospitals and other burns and trauma care institutes. Cerebella division is the specialty division marketing drugs meant for lifestyle diseases, neuro and psychiatric therapy. The brands of this division are BAZZY, CITOFAST, GABELLA, GABELLA M, XENOTRIL, which are the main contributors of sales.
          {"success":1,"data":{"address":{"address1":"11th Floor, Grandeur,","address2":"Veera Desai Extension Road,,Oshiwara, Andheri (West),","city":"Mumbai","state":"Maharashtra","pincode":"400053","telephone1":"022-40012000","telephone2":"","fax1":"022-40012011","fax2":"","email":"companysecretary@marksanspharma.com","web":"http:\/\/www.marksanspharma.com"},"management":[{"name":"Mark Saldanha","designation":"Chairman & Managing Director"},{"name":"Sandra Saldanha","designation":"Whole Time Director"},{"name":"Varddhman V Jain","designation":"Whole Time Director"},{"name":"Sunny Sharma","designation":"Non Executive Director"},{"name":"Digant Mahesh Parikh","designation":"Independent Director"}],"registrars":{"name":"Bigshare Services Pvt. Ltd.","address1":"S6-2, 6th Floor, Pinnacle Business Park,\nNext to A","address2":"","address3":"","address4":"","telephone":"022-62638200","fax":"022-62638261","email":"investor@bigshareonline.com","internet":"http:\/\/www.bigshareonline.com","city":"Mumbai","state":"Maharashtra","pincode":"400093"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"524404","nseId":"MARKSANS","series":"EQ","isinid":"INE750C01026"}}}
          • Registered Office

          • Registrars

          • Management

            • Mark Saldanha

              Chairman & Managing Director

            • Sandra Saldanha

              Whole Time Director

            • Varddhman V Jain

              Whole Time Director

            • Sunny Sharma

              Non Executive Director

            • Digant Mahesh Parikh

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              524404

            • NSE:

              MARKSANS

            • Series

              EQ

            • ISIN

              INE750C01026

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>